Heidelberg Pharma AG (XTER:HPHA) FCF Yield % : -25.08 (As of May. 25, 2024)

View and export this data going back to 2006. Start your Free Trial

What is Heidelberg Pharma AG FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Heidelberg Pharma AG's Trailing 12-Month Free Cash Flow is €-34.36 Mil, and Market Cap is €137.02 Mil. Therefore, Heidelberg Pharma AG's FCF Yield % for today is -25.08%.

The historical rank and industry rank for Heidelberg Pharma AG's FCF Yield % or its related term are showing as below:

XTER:HPHA' s FCF Yield % Range Over the Past 10 Years
Min: -89.41 Med: -16.43 Max: -3.35
Current: -25.08

During the past 13 years, the highest FCF Yield % of Heidelberg Pharma AG was -3.35%. The lowest was -89.41%. And the median was -16.43%.

XTER:HPHA's FCF Yield % is ranked worse than
63.55% of 1553 companies
in the Biotechnology industry
Industry Median: -14.53 vs XTER:HPHA: -25.08

Heidelberg Pharma AG's FCF Margin % for the quarter that ended in Feb. 2024 was -851.70%.

Heidelberg Pharma AG FCF Yield % Historical Data

The historical data trend for Heidelberg Pharma AG's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heidelberg Pharma AG FCF Yield % Chart

Heidelberg Pharma AG Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

FCF Yield %

Get a 7-Day Free Trial

-15.27

-11.97

-15.82

-3.56

-26.92

Heidelberg Pharma AG Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
FCF Yield %	Get a 7-Day Free Trial															-19.55	-17.58	-20.98	-22.46	-30.27

Competitive Comparison of Heidelberg Pharma AG's FCF Yield %

For the Biotechnology subindustry, Heidelberg Pharma AG's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Heidelberg Pharma AG's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Heidelberg Pharma AG's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Heidelberg Pharma AG's FCF Yield % falls into.

Heidelberg Pharma AG FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Heidelberg Pharma AG's FCF Yield % for the fiscal year that ended in Nov. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-34.632	/	128.6298
	=	-26.92%

Heidelberg Pharma AG's annualized FCF Yield % for the quarter that ended in Feb. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-10.791	*	4	/	142.6113
	=	-30.27%

Heidelberg Pharma AG FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Heidelberg Pharma AG FCF Yield % Related Terms

Thank you for viewing the detailed overview of Heidelberg Pharma AG's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Heidelberg Pharma AG (XTER:HPHA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Heidelberg Pharma AG (XTER:HPHA) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

HPHA:Germany HPHA:Germany HPHA:Germany

Address

Gregor-Mendel-Street 22, Ladenburg, DEU, 68526

Website

https://www.heidelberg-pharma.com

Heidelberg Pharma AG is a biopharmaceutical company. It is focused on oncology and develops the toxin Amanitin into cancer therapies using its proprietary Antibody Targeted Amanitin Conjugate (ATAC) technology platform and advances the biological mode of action of the toxin as a novel therapeutic principle. The proprietary lead candidate is HDP-101 which is a BCMA (B-cell maturation antigen) - ATAC for multiple myeloma. In addition, the company offers preclinical contract research services. It operates through the following business divisions: Customer Specific Research, Diagnostics, and TherapeuticS.

Executives

Prof. Dr. Andreas Pahl

Board of Directors

Heidelberg Pharma AG (XTER:HPHA) Headlines

No Headlines